Hisamitsu Pharmaceutical Co., Inc.

TSE:4530 Rapporto sulle azioni

Cap. di mercato: JP¥290.4b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Hisamitsu Pharmaceutical Gestione

Gestione criteri di controllo 1/4

Hisamitsu Pharmaceutical's Il CEO è Kazue Nakatomi, nominato in May2015, ha un mandato di 9.25 anni. possiede direttamente 0.33% delle azioni della società, per un valore di ¥ 983.20M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.1 anni e 10.3 anni.

Informazioni chiave

Kazue Nakatomi

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO9.3yrs
Proprietà del CEO0.3%
Durata media del management1.2yrs
Durata media del Consiglio di amministrazione10.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Sep 16
Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing

Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 20
Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year

Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Jul 26
Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Jul 11
Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year

Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Jun 27
Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00

Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Jun 13
Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

AMMINISTRATORE DELEGATO

Kazue Nakatomi (52 yo)

9.3yrs

Mandato

Mr. Kazuhide Nakatomi, also known as Kazue, serves as Chief Executive Officer since May 2019, President since May 2015 & Director since May 2007 at Hisamitsu Pharmaceutical Co. Inc. and served as its Chief...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Kazuhide Nakatomi
President9.3yrsNessun dato0.33%
¥ 970.2m
Naruhito Higo
Executive VPless than a yearNessun datoNessun dato
Nobuo Tsutsumi
Exe Officer of Legal Affairs10.3yrsNessun dato0.0068%
¥ 19.8m
Kosuke Sugiyama
Executive MD of Human Resourcesless than a yearNessun dato0.018%
¥ 51.5m
Tetsuo Akiyama
Senior Managing Executive Officerless than a yearNessun datoNessun dato
Kyu Saito
MD, Executive Officerno dataNessun dato0.0095%
¥ 27.7m
Shinichi Murayama
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Directorno dataNessun dato0.0082%
¥ 23.8m
Mitsutoshi Tsuruta
Senior Executive Officer & GM of Pharmaceutical Business Divisionno dataNessun datoNessun dato
Masaya Okuno
Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Divisionno dataNessun datoNessun dato
Koji Takiyama
Executive Officer3.3yrsNessun dato0.0041%
¥ 11.9m
Katsuhiko Akiyama
Senior Executive Officer & GM of MN Business Promotion Office1.7yrsNessun datoNessun dato
Tomoya Suzuki
Executive Officer and GM of the Regional Mass Sales Dept of Pharmaceuticals & Cosmetics Divisionless than a yearNessun datoNessun dato

1.2yrs

Durata media

58.5yo

Età media

Gestione esperta: Il team dirigenziale di 4530 non è considerato esperto (durata media 1.1 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Kazuhide Nakatomi
President17.3yrsNessun dato0.33%
¥ 970.2m
Nobuo Tsutsumi
Exe Officer of Legal Affairs10.3yrsNessun dato0.0068%
¥ 19.8m
Kosuke Sugiyama
Executive MD of Human Resources25.3yrsNessun dato0.018%
¥ 51.5m
Kyu Saito
MD, Executive Officer11.3yrsNessun dato0.0095%
¥ 27.7m
Shinichi Murayama
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director10.3yrsNessun dato0.0082%
¥ 23.8m
Koji Takiyama
Executive Officer3.3yrsNessun dato0.0041%
¥ 11.9m
Munehiko Hirano
Standing Corporate Auditor18.3yrsNessun dato0.0027%
¥ 7.9m
Tetsugo Matsuo
Part-time Outside Independent Director4.3yrsNessun dato0.0014%
¥ 3.9m
Yuichiro Anzai
Part-time Outside Independent Director4.3yrsNessun datoNessun dato
Kentaro Watanabe
Part Time Outside Corporate Auditor1.3yrsNessun datoNessun dato
Tamako Watanabe
Part Time Outside Independent Director1.3yrsNessun datoNessun dato

10.3yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 4530 è composto da personale esperto e esperto (durata media dell'incarico 10.3 anni).